Total Holdings
77
As of Oct 4, 2026
Fidelity Disruptive Medicine ETF
FMEDNASDAQFidelityEquity
$30.26Today:- (-)1Y +20.14%
As of Oct 16, 2026 close
- Assets (AUM)
- $51.42M
- Expense ratio
- 0.50%
- Dividend yield
- -
- Holdings
- 77
- 52-week range
- $23.48$32.99
- Volume (live)
- -
- Avg. volume (3M)
- 8.22K
FMED ETF Holdings: Fidelity Disruptive Medicine ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
36.3%
Share of fund assets
Assets (AUM)
$51.42M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 49 of 77 FMED Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 49 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | 10x Genomics, Inc. | Stock | 6.09% |
| 2 |  | Natera, Inc. | Stock | 4.47% |
| 3 |  | Thermo Fisher Scientific Inc. | Stock | 4.08% |
| 4 |  | Danaher Corporation | Stock | 3.75% |
| 5 |  | Illumina, Inc. | Stock | 3.61% |
| 6 |  | LifeStance Health Group, Inc. Common Stock | Stock | 3.21% |
| 7 |  | argenx NV ADR | Stock | 3.08% |
| 8 |  | Revolution Medicines, Inc | Stock | 2.90% |
| 9 | EPA:DIM | Sartorius Stedim Biotech S.A. | Stock | 2.64% |
| 10 |  | Moderna, Inc. | Stock | 2.51% |
| 11 |  | HeartFlow, Inc. | Stock | 2.40% |
| 12 |  | Alnylam Pharmaceuticals, Inc | Stock | 2.34% |
| 13 |  | Intuitive Surgical, Inc. | Stock | 2.13% |
| 14 |  | Cogent Biosciences, Inc. | Stock | 2.05% |
| 15 |  | Kymera Therapeutics, Inc | Stock | 1.89% |
| 16 |  | Kiniksa Pharmaceuticals International, plc | Stock | 1.89% |
| 17 |  | West Pharmaceutical Services, Inc | Stock | 1.87% |
| 18 |  | Insmed Incorporated | Stock | 1.83% |
| 19 |  | Twist Bioscience Corporation | Stock | 1.83% |
| 20 |  | Ascendis Pharma AS | Stock | 1.82% |
| 21 |  | Vaxcyte, Inc | Stock | 1.81% |
| 22 |  | Caris Life Sciences, Inc. Common Stock | Stock | 1.79% |
| 23 |  | Repligen Corporation | Stock | 1.77% |
| 24 |  | BrightSpring Health Services, Inc. | Stock | 1.76% |
| 25 |  | Guardant Health, Inc. | Stock | 1.72% |
| 26 |  | Edwards Lifesciences Corporation | Stock | 1.69% |
| 27 |  | Veeva Systems Inc | Stock | 1.57% |
| 28 | EBR:UCB | UCB SA | Stock | 1.57% |
| 29 |  | Amylyx Pharmaceuticals Inc. Common Stock | Stock | 1.54% |
| 30 |  | Viridian Therapeutics Inc | Stock | 1.34% |
| 31 |  | UnitedHealth Group Incorporated | Stock | 1.33% |
| 32 |  | Roivant Sciences Ltd | Stock | 1.26% |
| 33 |  | Enliven Therapeutics Inc. | Stock | 1.26% |
| 34 |  | Legend Biotech Corporation | Stock | 1.25% |
| 35 |  | Axsome Therapeutics, Inc | Stock | 1.10% |
| 36 |  | Kestra Medical Technologies, Ltd. Common Stock | Stock | 1.09% |
| 37 |  | Oruka Therapeutics, Inc. | Stock | 1.09% |
| 38 |  | Boston Scientific Corporation | Stock | 1.05% |
| 39 |  | Xenon Pharmaceuticals Inc | Stock | 1.03% |
| 40 |  | Veracyte, Inc | Stock | 0.95% |
| 41 |  | Waystar Holding Corp. Common Stock | Stock | 0.94% |
| 42 |  | Disc Medicine Inc. | Stock | 0.92% |
| 43 |  | MBX | Stock | 0.91% |
| 44 |  | Relay Therapeutics, Inc | Stock | 0.90% |
| 45 |  | Eli Lilly and Company | Stock | 0.88% |
| 46 |  | Stoke Therapeutics, Inc | Stock | 0.87% |
| 47 |  | Dianthus Therapeutics Inc. | Stock | 0.84% |
| 48 |  | Bruker Corporation | Stock | 0.78% |
| 49 |  | iRhythm Technologies, Inc | Stock | 0.76% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Fidelity Disruptive Medicine ETF Holdings
What are the top holdings in FMED?
As of Oct 4, 2026, Fidelity Disruptive Medicine ETF (FMED) holds 77 securities. The largest are 10x Genomics, Inc. (6.09%), Natera, Inc. (4.47%), Thermo Fisher Scientific Inc. (4.08%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is FMED's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 36.3% of FMED's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is FMED's sector allocation?
The Sector Allocation chart shows how FMED distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does FMED invest in?
FMED's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is FMED ETF?
FMED's diversification can be assessed by reviewing its 77 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.